Q1 Earnings Estimate for Hyperfine Issued By B. Riley

Hyperfine, Inc. (NASDAQ:HYPR) – Analysts at B. Riley issued their Q1 2025 earnings estimates for shares of Hyperfine in a research report issued to clients and investors on Wednesday, March 19th. B. Riley analyst Y. Zhi anticipates that the company will earn ($0.12) per share for the quarter. B. Riley currently has a “Buy” rating and a $1.20 target price on the stock. The consensus estimate for Hyperfine’s current full-year earnings is ($0.57) per share. B. Riley also issued estimates for Hyperfine’s Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.13) EPS and FY2025 earnings at ($0.49) EPS.

Hyperfine (NASDAQ:HYPR) last issued its quarterly earnings data on Monday, March 17th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.02. The company had revenue of $2.32 million for the quarter, compared to analyst estimates of $2.30 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. During the same period last year, the company earned ($0.15) earnings per share.

HYPR has been the topic of several other research reports. Wells Fargo & Company lifted their target price on shares of Hyperfine from $1.10 to $1.29 and gave the company an “equal weight” rating in a research report on Tuesday, March 18th. Lake Street Capital assumed coverage on Hyperfine in a report on Monday. They issued a “buy” rating and a $1.50 price objective on the stock.

Hyperfine Stock Performance

Hyperfine stock opened at $0.82 on Monday. The company’s fifty day moving average price is $1.06 and its 200 day moving average price is $1.00. The stock has a market capitalization of $60.16 million, a P/E ratio of -1.45 and a beta of 0.94. Hyperfine has a 1 year low of $0.76 and a 1 year high of $1.90.

Institutional Investors Weigh In On Hyperfine

Several institutional investors and hedge funds have recently added to or reduced their stakes in HYPR. Virtu Financial LLC purchased a new position in shares of Hyperfine in the fourth quarter worth about $25,000. Graypoint LLC acquired a new stake in Hyperfine in the 4th quarter valued at about $44,000. Wealth Enhancement Advisory Services LLC lifted its stake in Hyperfine by 64.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock worth $72,000 after purchasing an additional 32,093 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Hyperfine by 32.9% during the 4th quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock worth $187,000 after purchasing an additional 52,500 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Hyperfine by 18.7% during the 3rd quarter. Geode Capital Management LLC now owns 624,520 shares of the company’s stock worth $675,000 after purchasing an additional 98,335 shares during the last quarter. Institutional investors and hedge funds own 15.03% of the company’s stock.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.